Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-519644-33-00Phase 2Authorised
Phase 2, randomised, double-blind trial in oligospermia comparing Isotretinoin with Placebo (2 arms). Planned start Apr 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-519644-33-00.